STERIS plc Defined Benefit Plan, Plan Assets, Prescription Drug Subsidy Receipt
STERIS plc (STE) reported Defined Benefit Plan, Plan Assets, Prescription Drug Subsidy Receipt of $200.00 thousand for the 12-month period ending 2026-03-31, per its 10-K filed 2026-05-29.
Financial Statements › Notes › Compensation Related Costs › Retirement Benefits › Defined Benefit Plan › Defined Benefit Plan, Roll Forwards
us-gaap:DefinedBenefitPlanPlanAssetsPrescriptionDrugSubsidyReceipt · last filed 2026-05-29
- STERIS plc defined benefit plan, plan assets, prescription drug subsidy receipt for fiscal 2026 was $200.00K, a 33.33% decline from fiscal 2025.
- STERIS plc defined benefit plan, plan assets, prescription drug subsidy receipt for fiscal 2025 was $300.00K, a 11.50% decline from fiscal 2024.
- STERIS plc defined benefit plan, plan assets, prescription drug subsidy receipt for fiscal 2024 was $339.00K, a 28.93% decline from fiscal 2023.
- STERIS plc defined benefit plan, plan assets, prescription drug subsidy receipt for fiscal 2023 was $477.00K, a 27.73% decline from fiscal 2022.
| Period end | Defined Benefit Plan, Plan Assets, Prescription Drug Subsidy Receipt 12 month | Defined Benefit Plan, Plan Assets, Prescription Drug Subsidy Receipt 12 month as first filed |
|---|---|---|
| 2026-03-31 | $200.00K 10-K · filed 2026-05-29 | |
| 2025-03-31 | $300.00K 10-K · filed 2026-05-29 | $270.00K 10-K · filed 2025-05-29 |
| 2024-03-31 | $339.00K 10-K · filed 2025-05-29 | |
| 2023-03-31 | $477.00K 10-K · filed 2024-05-29 | |
| 2022-03-31 | $660.00K 10-K · filed 2023-05-26 | |
| 2021-03-31 | $899.00K 10-K · filed 2022-05-31 | |
| 2020-03-31 | $708.00K 10-K · filed 2021-05-28 | |
| 2019-03-31 | $706.00K 8-K · filed 2021-02-09 | |
| 2018-03-31 | $383.00K 10-K · filed 2019-05-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ZIMMER BIOMET HOLDINGS, INC. (ZBH) | United States | $17.103B | 20.66 |
| ALIGN TECHNOLOGY INC (ALGN) | United States | $10.346B | 29.06 |
| MSA Safety Inc (MSA) | United States | $7.023B | 21.47 |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | $1.954B | -65.76 | |
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Enovis CORP (ENOV) | United States | $1.053B | -1.18 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |
| Inogen Inc (INGN) | United States | $0.139B | -7.00 |
| Conexeu Sciences Inc. (CNXU) | United States | $0.111B |